Financial Ratios

ZENITH HEALTH CARE LTD.

NSE : NABSE : 530665ISIN CODE : INE812B01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.11-0.18 (-4.2 %)
PREV CLOSE ( ) 4.29
OPEN PRICE ( ) 4.23
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 63459
TODAY'S LOW / HIGH ( )4.08 4.23
52 WK LOW / HIGH ( ) 3.616.5
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.010.060.080.110.03
   CEPS(Rs)0.070.120.130.150.07
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.351.331.271.191.08
   Tax Rate(%)34.1248.7521.183.3017.52
Margin Ratios
   Core EBITDA Margin(%)0.232.052.284.522.14
   EBIT Margin(%)0.952.774.124.901.72
   Pre Tax Margin(%)0.902.714.064.841.68
   PAT Margin (%)0.591.393.204.681.39
   Cash Profit Margin (%)2.732.995.026.793.90
Performance Ratios
   ROA(%)0.753.115.287.602.03
   ROE(%)1.084.446.649.272.38
   ROCE(%)1.748.858.569.682.95
   Asset Turnover(x)1.272.241.651.621.46
   Sales/Fixed Asset(x)1.893.312.141.991.67
   Working Capital/Sales(x)2.564.493.083.012.74
Efficiency Ratios
   Fixed Capital/Sales(x)0.530.300.470.500.60
   Receivable days77.3640.2835.9929.2343.56
   Inventory Days95.5756.0969.9464.9871.02
   Payable days54.8941.9473.4363.6757.25
Valuation Parameters
   PER(x)274.48123.3669.268.4591.73
   PCE(x)59.7457.3044.155.8332.65
   Price/Book(x)2.965.364.450.752.16
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.561.632.160.201.17
   EV/Core EBITDA(x)50.4737.1636.342.7827.73
   EV/EBIT(x)163.2658.8652.393.9768.21
   EV/CE(x)2.243.163.520.291.73
   M Cap / Sales1.631.712.220.401.27
Growth Ratio
   Net Sales Growth(%)-41.2962.7514.7021.823.37
   Core EBITDA Growth(%)-58.6520.05-3.46103.32-39.16
   EBIT Growth(%)-79.759.26-4.22249.67-58.49
   PAT Growth(%)-74.95-29.40-22.22314.41-50.12
   EPS Growth(%)-74.91-29.40-22.25314.56-50.12
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)3.542.103.322.884.10
   Quick Ratio(x)1.921.301.621.942.11
   Interest Cover(x)17.1846.9166.1587.6345.37
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.